Synopsis:
This present study indicated that the plasma levels of NTproBNP and MAU increased synchronously in pace with the aggravation of heart failure, and there was a positive
correlation between MAU and NT-proBNP. To some extent, monitoring MAU might replace monitoring NTproBNP in patients with heart failure.